VanEck Morningstar Wide Moat ETF (ASX:MOAT)
Australia · Delayed Price · Currency is AUD 130.17
-0.43 (-0.33%)
Dec 1, 2025, 3:35 PM AEST
-1.63% (1Y)
| Assets | 1.02B |
| Expense Ratio | 0.49% |
| PE Ratio | 17.31 |
| Dividend (ttm) | 7.56 |
| Dividend Yield | 5.79% |
| Ex-Dividend Date | Jul 1, 2025 |
| Payout Frequency | Annual |
| Payout Ratio | 100.23% |
| 1-Year Return | +4.94% |
| Volume | 12,807 |
| Open | 130.79 |
| Previous Close | 130.60 |
| Day's Range | 130.03 - 130.83 |
| 52-Week Low | 110.21 |
| 52-Week High | 137.99 |
| Beta | 0.91 |
| Holdings | 10 |
| Inception Date | Jun 26, 2015 |
About MOAT
The VanEck Morningstar Wide Moat ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Morningstar Wide Moat Focus Index.
Asset Class Equity
Category Total Market
Stock Exchange Australian Securities Exchange
Ticker Symbol MOAT
Provider VanEck
Index Tracked Morningstar Wide Moat Focus Index - AUD
Performance
MOAT had a total return of 4.94% in the past year, including dividends. Since the fund's inception, the average annual return has been 15.34%.
Top 10 Holdings
29.38% of assets| Name | Symbol | Weight |
|---|---|---|
| Applied Materials, Inc. | AMAT | 3.56% |
| Thermo Fisher Scientific Inc. | TMO | 3.15% |
| Merck & Co., Inc. | MRK | 3.03% |
| Huntington Ingalls Industries, Inc. | HII | 3.00% |
| Agilent Technologies, Inc. | A | 2.98% |
| Amgen Inc. | AMGN | 2.87% |
| The Estée Lauder Companies Inc. | EL | 2.84% |
| West Pharmaceutical Services, Inc. | WST | 2.73% |
| Danaher Corporation | DHR | 2.72% |
| GE HealthCare Technologies Inc. | GEHC | 2.50% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jul 1, 2025 | 7.560 AUD | Jul 25, 2025 |
| Jul 1, 2024 | 9.730 AUD | Jul 23, 2024 |
| Jul 3, 2023 | 8.150 AUD | Jul 25, 2023 |
| Dec 21, 2021 | 1.3788 AUD | Jan 14, 2022 |
| Dec 22, 2020 | 1.33208 AUD | Jan 15, 2021 |
| Dec 24, 2019 | 1.27428 AUD | Jan 16, 2020 |